AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,926,336 | -0.7% | 353,502 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $9,997,037 | -5.2% | 353,502 | -25.7% | 0.00% | 0.0% |
| Q2 2022 | $10,547,001 | -26.9% | 475,733 | -4.1% | 0.00% | 0.0% |
| Q1 2022 | $14,435,416 | +113.5% | 495,892 | +141.1% | 0.00% | +200.0% |
| Q4 2021 | $6,760,000 | -50.4% | 205,646 | -30.4% | 0.00% | -66.7% |
| Q3 2021 | $13,640,000 | -36.8% | 295,557 | -24.5% | 0.00% | -40.0% |
| Q2 2021 | $21,581,000 | +54.8% | 391,591 | +45.1% | 0.01% | +66.7% |
| Q1 2021 | $13,938,000 | -43.6% | 269,902 | -52.6% | 0.00% | -50.0% |
| Q4 2020 | $24,691,000 | +26.5% | 569,836 | +2.2% | 0.01% | +20.0% |
| Q3 2020 | $19,517,000 | -60.8% | 557,625 | -40.1% | 0.01% | -64.3% |
| Q2 2020 | $49,818,000 | +34.5% | 931,521 | -10.8% | 0.01% | +7.7% |
| Q1 2020 | $37,036,000 | -25.7% | 1,043,854 | 0.0% | 0.01% | -7.1% |
| Q4 2019 | $49,844,000 | +211.5% | 1,043,854 | +111.4% | 0.01% | +180.0% |
| Q3 2019 | $16,001,000 | -23.2% | 493,854 | +18.2% | 0.01% | -16.7% |
| Q2 2019 | $20,841,000 | -26.0% | 417,825 | 0.0% | 0.01% | -33.3% |
| Q1 2019 | $28,178,000 | +46.3% | 417,825 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $19,267,000 | -31.8% | 417,825 | +14.0% | 0.01% | -22.2% |
| Q3 2018 | $28,262,000 | -8.4% | 366,476 | 0.0% | 0.01% | -18.2% |
| Q2 2018 | $30,868,000 | +3.0% | 366,476 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $29,971,000 | +65.6% | 366,476 | +15.8% | 0.01% | +83.3% |
| Q4 2017 | $18,093,000 | -14.4% | 316,476 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $21,125,000 | -33.5% | 316,476 | -48.8% | 0.01% | -38.5% |
| Q2 2017 | $31,777,000 | -13.4% | 617,634 | -1.7% | 0.01% | -13.3% |
| Q1 2017 | $36,676,000 | +344.8% | 628,027 | +217.8% | 0.02% | +275.0% |
| Q4 2016 | $8,246,000 | -26.3% | 197,611 | -10.9% | 0.00% | -20.0% |
| Q3 2016 | $11,184,000 | +20.4% | 221,697 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $9,288,000 | +127.1% | 221,697 | +120.1% | 0.00% | +100.0% |
| Q1 2016 | $4,090,000 | -59.5% | 100,731 | -35.3% | 0.00% | -60.0% |
| Q4 2015 | $10,102,000 | -15.4% | 155,610 | -7.9% | 0.01% | -16.7% |
| Q3 2015 | $11,934,000 | -46.9% | 169,049 | -16.4% | 0.01% | -45.5% |
| Q2 2015 | $22,482,000 | +83.4% | 202,293 | +55.6% | 0.01% | +83.3% |
| Q1 2015 | $12,259,000 | – | 129,994 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |